Ancient Pomegranate May Hold the Key to a Hard‑to‑Treat Heart Failure
- Nishadil
- October 12, 2026
- 0 Comments
- 2 minutes read
- 5 Views
- Save
- Follow Topic
Scientists discover that a compound from the Persian superfruit could improve heart‑muscle function in HFpEF patients
A molecule produced when we eat pomegranates – urolithin A – appears to help the heart relax and reduce scarring, offering new hope for the growing number of Americans with heart failure with preserved ejection fraction.
There’s nothing “seedy” about this story – it’s actually about a fruit that has been prized in Iran for millennia. The humble pomegranate, a bright‑red jewel on the table, might soon be celebrated in cardiology journals for a completely different reason.
Heart failure with preserved ejection fraction (HFpEF) is a mouthful, but the idea is simple: the heart can still pump blood, yet it struggles to relax and fill properly. It’s a stealthy, increasingly common condition – about 3 million Americans live with it now, and the number could soar past 11 million by mid‑century.
Researchers at King’s College London turned their attention to a post‑biotic called urolithin A. This isn’t a drug you buy at the pharmacy; it’s a molecule your gut microbes churn out after you munch on foods like walnuts, berries, and pomegranates. The catch? Only roughly 40 % of people make it efficiently on their own.
In a series of experiments that felt a bit like a sci‑fi movie, the team gave urolithin A to mice with HFpEF and to lab‑grown human heart tissue derived from stem cells. The results were striking – the hearts relaxed up to 80 % better, scar tissue shrank, and the dreaded enlargement of the organ was kept in check.
How does it work? The molecule nudges a protein known as PKGα into action. That protein, in turn, helps blood vessels and heart muscle fibers loosen up, making it easier for the heart to fill with blood between beats.
“Despite the growing burden of HFpEF, our therapeutic options are painfully limited,” said senior author Dr. Joseph Burgoyne in a press release. “Urolithin A’s safety profile in humans is already reassuring, which makes it a very attractive candidate for further study.”
Don’t mistake this for a miracle‑fruit cure. Eating a few pomegranates a day won’t magically reverse heart failure, but the findings hint that diets boosting urolithin A production could become part of a broader treatment strategy. Clinical trials in people are the next logical step.
Until then, the age‑old advice still holds: a balanced diet rich in whole foods, regular activity, and good blood‑pressure control remain the backbone of heart‑healthy living.
Editorial note: Nishadil may use AI assistance for news drafting and formatting. Readers can report issues from this page, and material corrections are reviewed under our editorial standards.